ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

Elevated Insights

From gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts

// Jan 2023

Reflecting on ElevateBio’s First Five Years

From our Chairman and CEO, David Hallal

View Insight

// Nov 2022

The Medicines of Tomorrow: A primer on the gene editing landscape

By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics

View Insight

// Nov 2022

Right from the start: Successfully managing the life cycles of cell and gene therapies

By Mike Paglia, Chief Operating Officer ElevateBio BaseCamp

View Insight

// Nov 2022

ElevateBio’s Lentiviral Vector Platform: Right the first time

By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBio

View Insight

// Nov 2022

Addressing Gaps in Cystic Fibrosis Treatment by Fixing Nonsense Mutations

By Alexandra Crawley, PH.D., Co-founder and Principal Investigator, Life Edit Therapeutics, Inc.

View Insight

MENU